“Alkaline water” fails to be an effective alternative for prevention of recurrent urinary stones

Bottled water marketed as “alkaline water” is unlikely to be an effective alternative for prevention of recurrent urinary stones, reports a study in the January issue of The Journal of Urology, an Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.

Opinion | It Shouldn’t Take Another Pandemic to Invest in Digital Health

Saldanha is chief innovation officer of a health system. The public health emergency, declared in 2020 as a result of the COVID pandemic, fostered the

August 7, 2023

FDA grants full approval to Leqembi, opening up coverage of Alzheimer’s drug by Medicare

For the first time in 20 years, the FDA has bestowed full approval on a drug to treat Alzheimer’s disease, opening the door to coverage

July 7, 2023

Association of estrogen-containing menopause hormonal therapy with COVID-19 mortality

Researchers evaluated coronavirus disease 2019 (COVID-19)-related mortality among perimenopausal women.

February 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.